The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectris Regulatory News (SXS)

Share Price Information for Spectris (SXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,306.00
Bid: 3,294.00
Ask: 3,306.00
Change: 0.00 (0.00%)
Spread: 12.00 (0.364%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3,306.00
SXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategy for Sustainable Growth and new targets

19 Oct 2022 07:00

RNS Number : 3323D
Spectris PLC
19 October 2022
 

Strategy for Sustainable Growth and new medium-term targets

19 October 2022 - Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, is today hosting a capital markets event to outline its Strategy for Sustainable Growth and provide new medium-term targets.

Andrew Heath, Chief Executive commented: "Since our last capital markets day in 2019, we have transformed Spectris into a more focused and higher quality business, well positioned in attractive markets with structural growth drivers that are closely aligned to our ambition to be a leading sustainable business. At today's capital markets event, we will demonstrate our confidence of compounding growth into the future, supported by organic investments and M&A, while continuing to expand operating margins. This Strategy for Sustainable Growth will deliver our new medium-term financial targets and drive long-term value for all our stakeholders."

Compounding growth model with new medium-term targets

Organic sales growth 6-7% through the cycle

Adjusted operating margin 20%+

Cashflow conversion 80-90%

ROGCE Mid-teens %

ESG Net Zero and employee engagement

 

Simplified reporting structure focused on two high quality divisions with compelling growth opportunities

Our businesses are focused on premium, precision measurement solutions, with industry-leading domain expertise, aligned with our Purpose to make the world cleaner, healthier and more productive.

The Group's new divisional reporting structure comprises two main divisions, best reflecting the growth and margin expansion potential of the Group:

•  Spectris Scientific - a leader in advanced measurement techniques for materials analysis, comprising Malvern Panalytical and Particle Measuring Systems; and

•  Spectris Dynamics - a leader in advanced, integrated physical and virtual testing as well ashigh precision sensing solutions, comprising HBK.

The two divisions both have significant market positions, with growth and margin expansion opportunities underpinned by leading product offerings and plans for investment in R&D and M&A.

The event will be led by Chief Executive, Andrew Heath, and will feature presentations fromChief Financial Officer, Derek Harding, and other members of the Spectris Executive Committee. The presentation will start at 13.30 and will be held at Landing 42, The Leadenhall Building, 122 Leadenhall Street, London EC3V 4AB. The presentation will also be webcast online. Details of the event can be found at: www.spectris.com/investors/capital-markets-day-2022/

A summary of the Group's 2021 results under the new divisions is presented below:

2021

Spectris Scientific

Spectris Dynamics

Other(non-reporting segments)

Group

 costs

Total

Sales (£m)

531.2

425.5

206.3

-

1,163.0

Adjusted operating profit (£m)

112.2

70.3

26.2

(19.1)

189.6

Adjusted operating margin (%)

21.1%

16.5%

12.7%

-

16.3%

Red Lion and Servomex will be reported in the 'Other' segment of our reporting going forward.

 

For and on behalf of Spectris plc

LEI Number: 213800Z4CO2CZO3M3T10

Contacts:

Spectris plc

Siobhán Andrews

Head of Corporate Affairs+44 20 4551 4549 / +44 7920 230093

Tulchan Communications

Martin Robinson

Giles Kernick

+44 20 7353 4200

About Spectris

Spectris' global group of businesses are focused on delivering value beyond measure for all our stakeholders. We target global, attractive and sustainable markets, where growth and high returns are supported by long-term drivers. Precision is at the heart of what we do. We provide customers with expert insight through our advanced instruments and test equipment, augmented by the power of our software and services. This equips customers with the ability to reduce time to market, improve processes, quality and yield. In this way, Spectris know-how creates value for our wider society, as our customers design, develop, test and manufacture their products to make the world a cleaner, healthier and more productive place. Headquartered in London, United Kingdom, Spectris employs approximately 7,350 people located in more than 30 countries. For more information, visit www.spectris.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAFEPFAPAFAA
Date   Source Headline
2nd May 20247:00 amRNSQ1 2024 trading update
1st May 20249:50 amRNSTotal Voting Rights
23rd Apr 20245:57 pmRNSDirector/PDMR Shareholding
9th Apr 20243:14 pmRNSDirector/PDMR Shareholding
8th Apr 20245:30 pmRNSHolding(s) in Company
3rd Apr 20246:26 pmRNSTransaction in Own Shares
3rd Apr 20245:20 pmRNSHolding(s) in Company
3rd Apr 20247:00 amRNSDivestment of Red Lion Controls completed
2nd Apr 20246:26 pmRNSTransaction in Own Shares
2nd Apr 202410:30 amRNSTotal Voting Rights
28th Mar 20246:29 pmRNSTransaction in Own Shares
28th Mar 202410:00 amRNSDirectorate Change
27th Mar 20245:56 pmRNSTransaction in Own Shares
27th Mar 20249:45 amRNSAnnual Financial Report
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20246:23 pmRNSTransaction in Own Shares
20th Mar 20246:44 pmRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20245:59 pmRNSTransaction in Own Shares
18th Mar 202411:37 amRNSDirector and Board Committee Membership Change
15th Mar 20246:10 pmRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20246:28 pmRNSTransaction in Own Shares
12th Mar 20246:06 pmRNSTransaction in Own Shares
11th Mar 20246:02 pmRNSTransaction in Own Shares
11th Mar 202412:33 pmRNSDirector/PDMR Shareholding
8th Mar 20246:00 pmRNSTransaction in Own Shares
8th Mar 20242:59 pmRNSDirector/PDMR Shareholding
7th Mar 20245:27 pmRNSTransaction in Own Shares
7th Mar 202411:32 amRNSDirector Declaration
6th Mar 20246:07 pmRNSTransaction in Own Shares
5th Mar 20246:03 pmRNSTransaction in Own Shares
4th Mar 20245:48 pmRNSTransaction in Own Shares
1st Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 202410:00 amRNSTotal Voting Rights
1st Mar 20247:46 amRNSDirector Declaration
29th Feb 20246:02 pmRNSTransaction in Own Shares
29th Feb 20247:00 amRNSFinal Results
28th Feb 20246:05 pmRNSTransaction in Own Shares
27th Feb 20246:04 pmRNSTransaction in Own Shares
26th Feb 20245:59 pmRNSTransaction in Own Shares
23rd Feb 20246:03 pmRNSTransaction in Own Shares
22nd Feb 20245:34 pmRNSTransaction in Own Shares
21st Feb 20245:58 pmRNSTransaction in Own Shares
20th Feb 20245:41 pmRNSTransaction in Own Shares
19th Feb 20245:38 pmRNSTransaction in Own Shares
16th Feb 20245:58 pmRNSTransaction in Own Shares
15th Feb 20246:05 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.